PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System

Inclusion Criteria: * Clinical Stage ≤ T2c * PSA ≤ 20 ng/ml * Prostate volume ≥ 30 ml * Grade Group (GG) 1 or 2: If GG 1: ≥ 3 cores positive for cancer. Note, multiple positive from any MRI targeted lesion will be considered as a single positive core. Exclusion Criteria: * Any prior or current treatment for prostate cancer, including but not limited to surgery, radiation therapy (external or brachytherapy), tissue ablation or chemotherapy. * Patients with previous surgical or minimally invasive treatment of benign prostatic hyperplasia within the prior 12 months. * Radiographically suspicious lymph node involvement confirmed with biopsy or PET scan. * Evidence of bone metastasis. * Evidence of extracapsular involvement. * Evidence of seminal vesicle invasion on DRE or MRI read as "definite", "probable" or "consistent with" * Any condition or history of illness or surgery that may pose an additional risk to men undergoing the Aquablation procedure.